Skip to main content

Market Overview

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response Coordinator Jeff Zients recently said the US in on track of meeting the goal of 200 million shots in 100 days.


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.


Related Articles (MRNA)

Posted-In: WIIM